Frontiers in Oncology (Aug 2023)
Editorial: The mechanism of tumor evolution and microenvironmental changes of genitourinary oncology in clinical diagnosis and treatment
- Jiahe Lu,
- Jiahe Lu,
- Jiahe Lu,
- Wen-Hao Xu,
- Wen-Hao Xu,
- Wen-Hao Xu,
- Hailiang Zhang,
- Hailiang Zhang,
- Hailiang Zhang,
- Dingwei Ye,
- Dingwei Ye,
- Dingwei Ye
Affiliations
- Jiahe Lu
- Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, China
- Jiahe Lu
- Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China
- Jiahe Lu
- Shanghai Genitourinary Cancer Institute, Shanghai, China
- Wen-Hao Xu
- Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, China
- Wen-Hao Xu
- Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China
- Wen-Hao Xu
- Shanghai Genitourinary Cancer Institute, Shanghai, China
- Hailiang Zhang
- Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, China
- Hailiang Zhang
- Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China
- Hailiang Zhang
- Shanghai Genitourinary Cancer Institute, Shanghai, China
- Dingwei Ye
- Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, China
- Dingwei Ye
- Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China
- Dingwei Ye
- Shanghai Genitourinary Cancer Institute, Shanghai, China
- DOI
- https://doi.org/10.3389/fonc.2023.1272984
- Journal volume & issue
-
Vol. 13
Abstract
No abstracts available.Keywords
- the tumor microenvironment (TME)
- genitourinary (GU)
- renal cell carcinoma (RCC)
- prostate adenocarcinoma (PRAD)
- bladder cancer (BCa)
